LARVOL

We're excited to announce that LARVOL will be featured on New Frontiers this January 2025! ?? ?? In this special episode, we’ll explore how our Oncology Data Intelligence empowers pharmaceutical and biotech companies to make strategic, data-driven decisions that fuel innovation. From clinical trial insights to expert opinions, we can’t wait to showcase the impact of our work. ?? We’d love for you to tune in and join us! ?? Access the full press release: https://bit.ly/4d9qkAf Stay tuned for more details! #LARVOL #NewFrontiersTV #Oncology #OncologyData #CancerResearch #CancerData #ComingJanuary2025 #DataInnovation #PressRelease #PlanetTVStudios

Late-breaking abstracts for the American Society of Hematology 2024 are here! Are you ready to dive into groundbreaking cancer research? Join LARVOL at ASH 2024 in San Diego, December 7-10, as we showcase our game-changing oncology data solutions. ?? Whether you're seeking insights, innovation, or impactful collaborations, let's connect and take cancer data intelligence to the next level. ?? See you in San Diego! #LARVOL #ASH2024 #Oncology #CancerResearch #CancerData #OncologyUdpates #Hematology

The latest episode of the LARVOL Onco Data Podcast is live! Join Mark Gramling and Darko Medin, as they explore Pseudo IPD in Cancer Research and the role of Network Meta-Analysis in oncology. Tune in now: https://bit.ly/3ZlpDQU #LARVOL #Oncology #CancerResearch #CancerData #OncoDataPodcast #MedicalPodcast #NetworkMetaAnalysis

In this episode, Mark Gramling is joined by Darko Medin for a dive into the complexities of network meta-analysis in oncology and its integration with pseudo-IPD (Individual Patient Data). The conversation explores how LARVOL’s CLIN platform is advancing data curation to enable comprehensive and predictive analyses in cancer research. Key topics include: ? The use of pseudo-IPD for combining treatment data ? The role of network meta-analysis in comparing multiple treatments simultaneously ? How combining direct and indirect evidence provides valuable insights in oncology Don’t miss out on this discussion on the power of big data and AI for more effective cancer treatment strategies.

?? Episode 8 of the 'LARVOL CLIN - Building In Public' Podcast is now live! Join Bruno Larvol and Kalpana Devi, Director at LARVOL, as they discuss the importance of the Landscape feature in LARVOL CLIN. This function compares main treatments with clinical trial data, offering valuable insights that serve as a guideline in oncology. It provides a comprehensive data table and the emerging data landscape for cancer patients. Tune in now: https://bit.ly/3V2Mwpr With LARVOL CLIN, stay informed and ahead in the fast-evolving world of oncology. Access key insights, stay updated on new developments, and leverage data intelligence to elevate your practice. Discover more: https://bit.ly/4da5h1k #LARVOL #Oncology #CancerResearch #MedicalOncology #CancerTreatment #OncologyUpdates #MedicalPodcast #LARVOLCLIN

Ahead of the American Society of Hematology 2024, we’ve highlighted the top diseases from the field of oncology. Save the date! We will be at ASH 2024 in San Diego, from December 7-10, showcasing innovative cancer data solutions. With LARVOL CLIN, you’ll remain at the cutting edge of the evolving oncology landscape. Access critical insights that drive your practice and stay ahead of industry trends. Don’t miss out—connect with us and stay informed ?? https://bit.ly/4da5h1k Connect with our leading oncology partners from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala| Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates

Are you ready for the American Society of Hematology 2024? We spotlight the leading MOAs. Connect us at ASH 2024 in San Diego, December 7-10, to explore the latest and AI-powered cancer data solutions. With LARVOL CLIN, you’ll be at the forefront of the rapidly evolving oncology landscape. Access essential insights that drive your practice and keep you updated on the latest industry trends. Stay ahead—connect with us and stay informed ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala| Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates

Ahead of the American Society of Hematology 2024, we're highlighting the top products from the dynamic field of oncology. Mark your calendars! LARVOL will be at ASH 2024 in San Diego from December 7-10, showcasing transformative cancer data solutions. To stay ahead of the curve in the ever-evolving oncology field and gain access to the critical insights that drive your practice, just connect with us at LARVOL CLIN ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates

In the lead-up to the American Society of Hematology 2024, we've spotlighted the top clinical trials trending among oncologists on X (formerly Twitter). Your oncology data partner, LARVOL is heading to ASH 2024! Meet us in San Diego for the latest cancer insights, December 7-10. Access the vital insights that drive your practice and stay updated on the latest from the dynamic oncology field with LARVOL CLIN ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Andrew Rezvani | Samer Al Hadidi | Raúl Córdoba Mascu?ano | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates

Leading up to the American Society of Hematology 2024, we're spotlighting the top companies driving innovation in oncology. Join LARVOL at ASH 2024 in San Diego to explore the latest in oncology data from December 7-10. Stay at the forefront of the rapidly advancing oncology landscape with LARVOL CLIN. Access the vital insights that matter most to your practice and stay informed about the latest industry breakthroughs ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates